Sonio
$192.5K 78 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Acorda Therapeutics, Inc
Acorda Therapeutics, Inc reported $192,542.83 across General Payments, Research, and Ownership to 2,002 physicians and teaching hospitals across 2,002 transactions.
- $192.5K Below-median payer
- All-tracks total
- 2,002 Top quartile volume
- Transactions
- 2,002 Top quartile reach
- Recipients
- −$339.0K
- General Payments vs PY2023
Acorda Therapeutics, Inc reported $192,542.83 across all CMS Open Payments tracks (General + Research + Ownership) to 2,002 physicians and teaching hospitals in Program Year 2024 - ranking #1014 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $192,542.83, averaging $96.18 per recipient.
Acorda Therapeutics, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
12/100
Transaction volume
F
25/100
Physician reach
F
25/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer acorda-therapeutics-inc Acorda Therapeutics, Inc
$192.5K · #1014/1,925 · 0.0% industry · PY2024
- TOT $192.5K
- RANK #1014
- SHARE 0.0%
- TXN 2,002
- RCP 2,002
- CAT 4
- GEN $192.5K
- ΔGEN −$339.0K
- TOP1 14.0%
- PY 2024
Volume peers
Nearest volume peer: Sonio ($192.5K)
Acorda Therapeutics, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Acorda Therapeutics, Inc's CMS-reported General Payments decreased by $339.0K (−63.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ACORDA THERAPEUTICS, INCPY2023: ACORDA THERAPEUTICS, INCPY2024: Acorda Therapeutics, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $531,566.85
- PY2024
- $192,542.83
What the Data Shows for Acorda Therapeutics, Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Acorda Therapeutics, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Compensation for Services Other Than Consulting" leads the 4-category general-payment breakdown below at $142.0K (73.8% of General Payments, 55 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Acorda Therapeutics, Inc made 4 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $142.0K, 73.8% of General Payments.
Acorda Therapeutics, Inc reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (73.8%), Food and Beverage (20.7%), and Travel and Lodging (5.1%). The remaining 1 category make up 0.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Acorda Therapeutics, Inc divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $142.0K | 55 | 73.8% |
| Food and Beverage | $39.9K | 1,897 | 20.7% |
| Travel and Lodging | $9.8K | 48 | 5.1% |
| Consulting Fee | $869.00 | 2 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $84,139.78 (43.7%) of $192,542.83 in this company's General Payments records across 1,109 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Acorda Therapeutics, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Indu Subramanian
$26,935.20 across 23 reported transactions
- 2
Stuart Isaacson
$26,481.62 across 21 reported transactions
- 3
Khashayar Dashtipour
$11,119.34 across 8 reported transactions
- 4
Roman Politi
$10,505.62 across 14 reported transactions
- 5
Ramsey a Falconer
$9,098.00 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Acorda Therapeutics, Inc's spend rank (#1014 of 1,925, bottom 47% by spend) and concentration rank (#1,243 of 1,838, bottom 32% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Merck KGaA : $285.7K total payments, HHI 587
- CONMED Corporation : $945.9K total payments, HHI 586
- Accuray Incorporated : $113.0K total payments, HHI 584
- IlluminOss Medical, Inc. : $168.9K total payments, HHI 583
- Medacta USA, Inc. : $8.4M total payments, HHI 583
- Kub Technologies Inc. : $14.7K total payments, HHI 583
- Acorda Therapeutics, Inc (this company) : $192.5K total payments, HHI 580
- Bayer Healthcare LLC : $279.6K total payments, HHI 578
- Nexxt Spine LLC : $292.8K total payments, HHI 576
- Solta Medical, a division of Bausch Health US, LLC : $585.9K total payments, HHI 572
- Bisco, Inc. : $180.9K total payments, HHI 571
- Gramercy Extremity Orthopedics LLC : $51.0K total payments, HHI 569
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Acorda Therapeutics, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Acorda Therapeutics, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Acorda Therapeutics, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Carestream Health, Inc.
$193.5K 21 recipients
Compare payment profiles
NanoFuse Biologics LLC
$193.9K 0 recipients
Compare payment profiles
Pulpdent Corporation
$194.0K 159 recipients
Compare payment profiles
Medicem Inc.
$194.1K 94 recipients
Compare payment profiles
Channel Medsystems, Inc.
$194.3K 521 recipients
Compare payment profiles
Put this to use
Acorda Therapeutics, Inc ranks #1014 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Acorda Therapeutics, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.